Articles

Quick Quiz: Colorectal Cancer Edition
According to the National Cancer Institute, colorectal cancer is the fourth most frequently diagnosed cancer in the United States, with approximately 52,550 deaths from the disease occurring in 2023. As the nation spotlights colorectal cancer awareness this March, test your knowledge here! Read More ›

Quick Quiz: Genetic Mutations in Clinical Decision-Making
Our understanding of the mechanisms of cell transformations in cancer driver genes is key to developing more effective cancer detection methods and therapeutic approaches. Test your knowledge of cancer genes and the treatments that target them. Read More ›

Quick Quiz: Immunotherapy in Cancer Edition
Immunotherapy has transformed the face of cancer care, and according to the AACR, it’s one of the 5 pillars of cancer treatment. How much do you know about immunotherapy? Test your knowledge here! Read More ›

Navigating Myelodysplastic Syndromes (MDS)
AONN+, with support from Gilead Sciences, is delighted to introduce you to a resource to support in educating your patients and caregivers in understanding the journey through Myelodysplastic Syndromes (MDS). Read More ›

Adjuvant treatment options for premenopausal women with hormone receptor–positive breast cancer now include endocrine therapy and ovarian function suppression (OFS) based on clinicopathologic characteristics that determine composite risk of recurrence. Read More ›

Understanding the role of the estrogen receptor (ER) in the pathogenesis of breast cancer has led to the development of treatment options that lead to reduced estrogen levels. In addition, the expression level of ER can serve as a prognostic indicator for disease recurrence and treatment response. Read More ›

With the availability of approaches for preserving fertility and ovarian function, physicians should be prepared to discuss the impact of chemotherapy on fertility and ovarian function with patients newly diagnosed with breast cancer in order to personalize treatment plans based on patients’ goals. In the modern era, an increasing number of women are opting to delay pregnancy. Read More ›

Measuring estradiol levels during ovarian function suppression (OFS) remains debatable. It can be argued that the assessment of estradiol levels is clinically irrelevant since general OFS can be achieved with the currently available approaches, and the outcomes of OFS trials are not based on estradiol levels. However, a variety of factors may lead to ovarian escape (OE). Read More ›

Despite the fact that 51% of patients with breast cancer have reported fertility concerns, evidence indicates that fertility preservation methods are underutilized. Read More ›

Studies have demonstrated that at least half of patients undergoing treatment for breast cancer are concerned about potential infertility and demonstrate interest in becoming pregnant after the conclusion of their treatment. Even those not interested in pregnancy seek to avoid ovarian insufficiency and early menopause, which can negatively impact patients’ quality of life—an important treatment goal. Read More ›

Page 1 of 396


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: